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B-cell acute lymphoblastic leukemia (B-ALL) is a neoplasm of immature lymphoid progenitors and is the
leading cause of cancer-related death in children. The majority of B-ALL cases are characterized by
recurring structural chromosomal rearrangements that are crucial for triggering leukemogenesis, but do not
explain all incidences of disease. Therefore, other molecular mechanisms, such as alternative splicing and
epigenetic regulation may alter expression of transcripts that are associated with the development of B-
ALL. It is important to investigate alternatively spliced RNA transcripts that may be affected by aberrant
DNA methylation in B-ALL to gain a better understanding of the pathogenesis of this disease. 
The goal of this thesis is to characterize the transcriptome landscape of patients with B-ALL using high
throughput RNA-sequencing (RNA-seq) analysis. Specifically, the study aims to identify particular genes
and their isoforms that might be controlled by aberrant DNA methylation in B-ALL and contribute to the
development of this disease. By analyzing transcriptional patterns between B-ALL patients and healthy cord
blood donors differentially expressed and alternatively spliced RNA transcripts have been identified. By
examining differentially expressed genes with Ingenuity pathway analysis, the most significant signaling
pathways and gene functions have been annotated. By analyzing causative gene networks, novel upstream
regulators have been determined for B-ALL patients. Finally, a mechanistic study has been conducted
using an in vitro B-ALL model to investigate if aberrant DNA methylation affects alternatively spliced genes
associated with this disease.  
Our pathway-centric approach may help to explore and characterize novel aberrant gene expression
patterns for B-ALL patients, thereby complementing previous research findings aimed at deciphering the
pathogenesis of B-ALL. Moreover, identified alternatively spliced transcripts may help better understand the
molecular basis of post-transcriptional gene regulation in the context of B-ALL. By inferring a role for DNA
methylation in the expression of alternatively spliced isoforms, new avenues might be explored for improved
diagnosis, management and treatment of B-ALL patients in the future.
